Cyberonics Receives FDA Real-Time Review Approval For New VNS Therapy Perennia Lead (Medical News Today)
Cyberonics, Inc. (Nasdaq:CYBX) today announced that it received FDA Real-Time Review approval forits new VNS Therapy(TM) Perennia(TM) Lead. The Perennia Lead, which isconnected to the VNS Therapy System Generator and attached to the leftvagus nerve, can be used with the current Model 102 and the futureDemipulse(TM) Pulse Generators (Models 103 and 104). [click link for full article]

Track-And-Trace Solutions: Domino Welcomes FDA's Vote Of Confidence In Hybrid Track-And-Trace Solutions (PharmaceuticalOnline)
Domino's Integrated Solutions Group has welcomed the recent Compliance Policy Guide announcement by the US Food and Drug Administration (FDA) as a major boost to the implementation of hybrid product traceability solutions combining RFID with existing data-carrier technology to provide counterfeit-proof 'e-pedigrees' throughout the pharmaceutical supply chain.